Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Stopped early · Phase 2
Conditions studied: Leukemia
In brief
RATIONALE: Drugs used in chemotherapy, such as clofarabine and daunorubicin, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving clofarabine together with daunorubicin may kill more cancer cells. PURPOSE: This phase II trial is studying how well giving clofarabine together with daunorubicin works in treating older patients with newly diagnosed acute myeloid leukemia.
Key facts
- Study ID
- NCT00814164
- Run by
- Roswell Park Cancer Institute
- People needed
- 21
- Starts
- 2008-12-01
- Expected to finish
- 2013-08-01
- Last updated by the study team
- 2016-08-17
Who can join
Age: 60 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Roswell Park Cancer Institute — Buffalo, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.